Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tobler

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|November 8, 2001
Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytesM P Tschan, S Vonlanthen, J F Cajot, et al.
European Journal of Haematology|October 1, 1990
Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemiaM F Fey, A Tobler, B Stadelmann, et al.
Blood|July 15, 1995
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodS Takeuchi, C R Bartram, T Seriu, et al.
Oncogene|November 23, 2005
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1C Britschgi, M Rizzi, T J Grob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)M Fopp, M F Fey, M Bacchi, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Oncogene|December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpressionS Vonlanthen, J Heighway, M P Tschan, et al.
Journal of Chemical Ecology|March 5, 2008
Inter- and intraspecific comparisons of antiherbivore defenses in three species of rainforest understory shrubsR M Fincher, L A Dyer, C D Dodson, et al.
International Journal of Cancer|August 30, 2000
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumoursD Zwahlen, M P Tschan, T J Grob, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|November 8, 2001
Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytesM P Tschan, S Vonlanthen, J F Cajot, et al.
European Journal of Haematology|October 1, 1990
Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemiaM F Fey, A Tobler, B Stadelmann, et al.
Blood|July 15, 1995
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodS Takeuchi, C R Bartram, T Seriu, et al.
Oncogene|November 23, 2005
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1C Britschgi, M Rizzi, T J Grob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)M Fopp, M F Fey, M Bacchi, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Oncogene|December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpressionS Vonlanthen, J Heighway, M P Tschan, et al.
Journal of Chemical Ecology|March 5, 2008
Inter- and intraspecific comparisons of antiherbivore defenses in three species of rainforest understory shrubsR M Fincher, L A Dyer, C D Dodson, et al.
International Journal of Cancer|August 30, 2000
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumoursD Zwahlen, M P Tschan, T J Grob, et al.
Pageof 16